Evidence map›Paper›PMID 14532198›Full record

ArticleJournal of clinical microbiology2003

emm typing of M nontypeable invasive group A streptococcal isolates in Israel.

Allon E Moses, Carlos Hidalgo-Grass, Mary Dan-Goor, Joseph Jaffe, Ilanit Shetzigovsky, Miriam Ravins, Zinaida Korenman, Ronit Cohen-Poradosu, Ran Nir-Paz

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 34 citations in OpenAlex.

  1. Frontiers in cellular and infection microbiology · 2017
    Article
  2. Macrolide resistance in Streptococcus species.Journal of pharmacy & bioallied sciences · 2015
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections.Proceedings of the National Academy of Sciences of the United States of America · 2004
    Article
  14. Group G streptococcal bacteremia in Jerusalem.Emerging infectious diseases · 2004
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Allon E MosesDepartment of Clinical Microbiology and Infectious Diseases, Hadassah University Medical Center, Jerusalem, Israel. MOSESA@MD2.HUJI.AC.IL
Carlos Hidalgo-Grass
Mary Dan-Goor
Joseph Jaffe
Ilanit Shetzigovsky
Miriam Ravins
Zinaida Korenman
Ronit Cohen-Poradosu
Ran Nir-Paz
University Medical Center · USHebrew University of Jerusalem · ILIsrael Ministry of Health · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We performed emm typing of M nontypeable invasive group A streptococcal (GAS) isolates collected in a prospective population-based study in Israel. One hundred twenty of 131 isolates (92%) had emm sequences compatible with GAS, consisting of 51 different emm types. Eleven isolates were found to be group G streptococcus. Of the 120 isolates, 55 (46%) belonged to 32 types for which there were no typing sera available in the Streptococcal Reference Laboratory in Israel. The other 65 (64%) isolates, consisting of 19 types, had sera available and therefore could have been serotyped. Forty-three isolates had T and emm types which were not correlated according to standard M-typing protocols and were therefore missed. The principal effect of emm typing was the addition of 32 types not previously identified in Israel and the discovery of new associations between emm and T types. emm typing did not significantly change the proportion of M types; the five most common types were 3, 28, 2, 62, and 41. Twenty different types comprised 80% of all isolates. No new emm sequences were discovered. emm typing emphasized the unusually low incidence of M1 strains causing severe disease in Israel. As serological typing of GAS becomes more problematic due to lack of sera and the appearance of new emm types, reference laboratories should replace M typing with emm sequence typing. Development of a GAS vaccine relies on the emm type distributions in different geographical locations. In our study, 7% of isolates (types 41 and 62) are not included in a 26-valent vaccine that is being studied.

Indexed as

Antigens, BacterialBacterial Outer Membrane ProteinsBacterial Typing TechniquesCarrier ProteinsHumansIsraelProspective StudiesSequence Analysis, DNASerotypingStreptococcal InfectionsStreptococcus pyogenesAntigens, BacterialBacterial Outer Membrane ProteinsCarrier Proteinsstreptococcal M protein

Identifiers

PMID14532198
PMCPMC254353
OpenAlexW2121283082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.